Feb. 27, 2026
Lymphoma Treatment Linked to Mild Skin Reactions
Study finds 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop photodistributed skin issues.
Feb. 24, 2026
Mom Pleads for Stem Cell Donor to Save 17-Year-Old Son with Rare Leukemia
Kerynn Morss is desperately searching for a match for her son Broeden Sabin, who was diagnosed with acute myeloid leukemia in December 2025.
Feb. 23, 2026
Top Barriers to Adopting Healthy Habits in Cancer Patients Revealed
Lack of energy and physical limitations emerge as the biggest hurdles, according to a national survey.
Feb. 22, 2026
Abdominal Fat, Not the Scale, Emerging as Stronger Indicator of Cancer Risk
Researchers say hidden visceral fat may drive inflammation and tumor growth even in people with normal BMI.
Feb. 22, 2026
Health Systems Invest $4 Billion in Cancer Care Expansion
Hospitals and health systems across the U.S. are expanding cancer care capacity and decentralizing access to improve oncology services.
Feb. 21, 2026
Father Makes Heartbreaking Plea as Search for 15-Year-Old Son's Life-Saving Donor Becomes Race Against the Clock
Juan Uribe reached 11.7 million people within 24 hours of posting his plea for help on TikTok
Feb. 16, 2026
Hazardous Chemicals Found in Popular Hair Extensions
Study reveals concerning levels of cancer-linked substances in unregulated beauty products.
Feb. 16, 2026
Hazardous Chemicals Found in Popular Hair Extensions
Study reveals cancer-linked substances in majority of products tested, raising concerns about health risks
Feb. 14, 2026
Dana-Farber, Gustave Roussy Host Oncology Drug Talks
The Fifth Transatlantic Exchange in Oncology will feature leading cancer researchers and clinicians from the US and Europe.
Feb. 12, 2026
Hair Extensions Contain Hazardous Chemicals, Study Finds
Researchers identified dozens of potentially harmful substances, including some linked to cancer and hormone disruption.
Feb. 12, 2026
Helsinki University Hospital Opens Europe's First In-Hospital Boron Neutron Capture Therapy Facility
Neutron Therapeutics and HUS celebrate the milestone with a ribbon-cutting ceremony attended by Finnish government officials.
Feb. 10, 2026
Olaparib Shows Promise in Metastatic Breast Cancer With Certain Genetic Mutations
Study finds olaparib effective in patients with germline PALB2 mutations and somatic BRCA1/2 mutations
Feb. 9, 2026
Senior Vizsla Celebrates End of Cancer Treatment
11-year-old dog rings chemotherapy bell after months of surgeries and therapy
